Results 211 to 220 of about 407,552 (296)

Diagnosis of bacteraemia in neonatal foals using 16S rRNA high‐throughput sequencing

Equine Veterinary Journal, EarlyView.
Abstract Background Sepsis is an important cause of morbidity and mortality in foals. Early diagnosis can improve outcome but is complicated by non‐specific clinical signs and delayed confirmation of infection via blood culture. Molecular assays represent a rapid and more sensitive alternative.
Flavie Payette, Alicia E. Long, Weiming Hu, Kyle Bittinger, Ahmed M. Moustafa, Darko Stefanovski, Michelle Abraham, Maia R. Aitken   +7 more
wiley   +1 more source

Efficacy of intravenous immunoglobulin following plasma exchange in the management of ABO haemolytic disease of the newborn. [PDF]

Vox Sang
Hu Y, Nie J.
europepmc   +1 more source

Antibody kinetics against tetanus toxoid before and after primary vaccination of foals

Equine Veterinary Journal, EarlyView.
Abstract Background Vaccination recommendations for foals against Clostridium tetani vary. Available studies assessing foal immune responses, maternal antibody interference, or individual variation often used small foal numbers. Objectives To quantify antibody responses after tetanus vaccination in foals and explore associations with passively ...
Katharina Olbrich, Monica Venner, Bettina Wagner   +2 more
wiley   +1 more source

Cost minimization analysis of subcutaneous and intravenous immunoglobulin treatment in Italy. [PDF]

Glob Reg Health Technol Assess
Bini C, Scortichini M, Ripoli S, Fioravanti L, Papa C, Sciattella P.   +5 more
europepmc   +1 more source

Engineering mRNA‐LNP Medicines for the Ageing Brain: Opportunities and Challenges for Neurodegenerative Diseases

Exploration, EarlyView.
This review highlights recent advances in engineering messenger RNA (mRNA)‐lipid nanoparticles (LNPs) to cross the ageing blood–brain barrier and target neurodegenerative diseases. It outlines design principles, delivery routes, and translational challenges, charting a roadmap towards clinical application of mRNA‐LNP therapeutics for neurodegenerative ...
Abdel Ali Belaidi, Denzil L. Furtado, Francesca Alves, Rebecca M. Nisbet, Scott Ayton, Ashley I. Bush   +5 more
wiley   +1 more source

Serum immunoglobulin G predicts mortality and stratifies intravenous immunoglobulin benefit in sepsis patients

Military Medical Research
Yuan-Yuan Hu, Ming-Min Pang, Hao-Yu Wang, Wen-Xiong Li, Hao Wang   +4 more
doaj   +1 more source

Predictive Factors for Non-response to First Use of Polyvalent Intravenous Immunoglobulin in Generalised Myasthenia Gravis. [PDF]

Neurol Ther
Dion M, Gavoille A, Chamouard V, Pegat A, Bouhour F.   +4 more
europepmc   +1 more source

The effects of intravenous immunoglobulin on intestinal inflammation: a systematic review of animal and clinical studies. [PDF]

PeerJ
Chu T, Yuan X, Wang T, Zhang W, Yan X, Li C, Jiang P, Ye S, Ma L, Sun P, Du X, Fu P, Wang Z.   +12 more
europepmc   +1 more source

Tolerability of Adjuvant Nivolumab in Esophageal or Gastroesophageal Junction Cancer: A Real‐World Study

International Journal of Cancer, EarlyView.
ABSTRACT Adjuvant nivolumab is approved for esophageal or gastroesophageal junction cancer after neoadjuvant chemoradiotherapy and resection. In the CheckMate‐577 trial, Grade 3–5 nivolumab‐related adverse events (AEs) occurred in 5% of patients, with early discontinuation due to toxicity in 9%. However, real‐world data on immunotherapy‐related adverse
Michelle Koops van ’t Jagt, Anniek Strijdhorst, Tamara Jessica Huizer, Esther Albertien Kleibeuker, Sarah Derks, Bianca Mostert, Hanneke van Laarhoven, Jacco Juri de Haan   +7 more
wiley   +1 more source

Intravenous Immunoglobulin Resistant Incomplete Kawasaki Disease in a 4-Month-Old Infant: A Case Report. [PDF]

Clin Case Rep
Yadav S, Poudel A, Karki H, Basnet B, Paudel S, Amatya P, Thapa P, Ojha AR, Basnet S.   +8 more
europepmc   +1 more source